A pharmaceutical composition comprising selegiline for preventing or treating acute myeloid leukemia

摘要

The present invention relates to a pharmaceutical composition for preventing or treating refractory or recurrent acute myeloid leukemia comprising selegiline as an active ingredient. Unlike conventional anticancer drugs, selegiline has excellent apoptosis effect not only on acute myeloid leukemia cells but also on refractory or recurrent acute myeloid leukemia cells, so that acute myeloid leukemia, in particular, refractory or recurrent acute myeloid leukemia. It can be usefully used as a pharmaceutical composition for preventing or treating leukemia.